Bardin Hill Management Partners LP Boosts Position in Amedisys, Inc. (NASDAQ:AMED)

Bardin Hill Management Partners LP grew its stake in Amedisys, Inc. (NASDAQ:AMED) by 21.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 120,471 shares of the health services provider’s stock after purchasing an additional 21,330 shares during the quarter. Amedisys makes up approximately 4.5% of Bardin Hill Management Partners LP’s holdings, making the stock its 4th biggest holding. Bardin Hill Management Partners LP’s holdings in Amedisys were worth $11,059,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Allianz Asset Management GmbH boosted its holdings in shares of Amedisys by 146.0% in the 4th quarter. Allianz Asset Management GmbH now owns 39,855 shares of the health services provider’s stock valued at $3,789,000 after buying an additional 23,655 shares during the period. Treasurer of the State of North Carolina lifted its stake in Amedisys by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider’s stock valued at $1,350,000 after buying an additional 140 shares during the last quarter. Gabelli Funds LLC boosted its holdings in shares of Amedisys by 24.7% during the fourth quarter. Gabelli Funds LLC now owns 224,125 shares of the health services provider’s stock valued at $21,305,000 after acquiring an additional 44,340 shares during the period. GABELLI & Co INVESTMENT ADVISERS INC. lifted its position in Amedisys by 23.7% in the 4th quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 201,523 shares of the health services provider’s stock valued at $19,157,000 after purchasing an additional 38,550 shares during the last quarter. Finally, Privium Fund Management UK Ltd acquired a new position in Amedisys during the 4th quarter valued at about $726,000. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AMED has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target on the stock. in a research note on Monday, July 29th. Cantor Fitzgerald restated a “neutral” rating and issued a $101.00 target price on shares of Amedisys in a research report on Thursday, July 25th. Finally, William Blair lowered Amedisys from an “outperform” rating to a “market perform” rating in a research report on Monday, July 1st. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Amedisys has an average rating of “Hold” and a consensus target price of $100.67.

Amedisys Trading Down 0.7 %

Amedisys stock opened at $95.85 on Wednesday. The stock has a market capitalization of $3.13 billion, a PE ratio of -149.77, a price-to-earnings-growth ratio of 1.90 and a beta of 0.78. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. Amedisys, Inc. has a 12-month low of $89.55 and a 12-month high of $98.95. The firm has a 50 day simple moving average of $97.55 and a 200-day simple moving average of $95.02.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.10. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. The firm had revenue of $591.19 million for the quarter, compared to analyst estimates of $579.34 million. As a group, equities research analysts expect that Amedisys, Inc. will post 4.66 EPS for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.